Year
2019
Authors
RAMOS Sofia, DE POUVOURVILLE Gérard, GOODALL G., LAMOTTE M., MAUNOURY F., PEJCHALOVA B.
Abstract
Transcatheter aortic valve implantation (TAVI) has become the therapy of choice for treating severe aortic stenosis in patients at high-risk for surgery or where it is considered too risky to attempt. We sought to evaluate the potential cost and clinical impact of TAVI in intermediate risk patients from a French collective perspective.
GOODALL, G., LAMOTTE, M., RAMOS, S., MAUNOURY, F., PEJCHALOVA, B. et DE POUVOURVILLE, G. (2019). Cost-effectiveness analysis of the SAPIEN 3 TAVI valve compared with surgery in intermediate-risk patients. Journal of Medical Economics, 22(4), pp. 289-296.